Key result
Elevated TyG-WHTR is linked to ~76% higher cardiovascular mortality in patients with hyperuricemia.
Why the study?
Do elevated insulin resistance-related indices predict adverse cardiovascular events and mortality in patients with hyperuricemia?
Cohort (n=48,533)
Yes
Do elevated insulin resistance-related indices predict adverse cardiovascular events and mortality in patients with hyperuricemia?
Answers are grounded in this paper and cite their sources.
Insulin resistance indices, particularly TyG-WHTR and CMI, effectively stratify cardiovascular mortality and myocardial infarction risk in patients with hyperuricemia, partially mediated by systemic inflammation and accelerated biological aging.
Background Hyperuricemia (HUA) frequently coexists with glucolipid metabolic disturbances characterized by insulin resistance, dyslipidemia, and adipose tissue dysfunction. However, the association between insulin resistance (IR)-related indices and cardiovascular disease (CVD) incidence/mortality in HUA patients remains not yet fully established. Methods Data from the UK Biobank (UKBB) and Shanghai Pudong cohort were analyzed, enrolling 35,853 and 12,680 HUA patients, respectively. Associations between seven IR-related indices and adverse cardiovascular events were assessed using multivariate Cox proportional hazards models, restricted cubic spline analyses, time-dependent receiver operating characteristic, random forest modeling, and Mendelian randomization. Mediation analyses evaluated the role of phenotypic aging biomarkers and inflammatory markers in these relationships. Results All seven IR indices exhibited significant associations with CVD events and mortality in HUA patients from two cohorts. TyG-WHTR showed comparable 10-year CVD mortality predictive performance to SCORE2 in UKBB (AUC, 0.733). Elevated TyG-WHTR correlated with increased CVD mortality [T3 vs. T1: HR, 1.76 (95%CI: 1.48–2.11)], while higher CMI predicted myocardial infarction [HR, 1.52 (1.31–1.76)]. C-reactive protein (mediation ratio: 1.3–13.3%) and accelerated aging (4.5–34.4%) partially mediated these associations. Genetically predicted TyG index elevation was linked to myocardial infarction risk [OR, 1.79 (1.48–2.16)]. Conclusion IR-related indices serve as clinically valuable tools for CVD risk stratification in HUA, with inflammatory activation and accelerated aging constituting key mechanistic pathways. These findings provide novel insights for early identification and targeted prevention of cardiovascular complications in HUA patients.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) conducted a cohort in Hyperuricemia (n=48,533). Elevated insulin resistance-related indices (TyG, TyG-BMI, TyG-WC, TyG-WHTR, TG/HDL-C, METS-IR, CMI) vs. Lowest tertile (T1) of insulin resistance-related indices was evaluated on Cardiovascular disease (CVD) mortality (for TyG-WHTR T3 vs. T1 in UK Biobank) (HR 1.76, 95% CI 1.48-2.11, p=<0.05). Elevated TyG-WHTR (T3 vs. T1) was associated with a 76% increased risk of cardiovascular mortality in patients with hyperuricemia.
Synapse has enriched 10 related papers. Consider them for comparative context: